Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future

Steven B Black*, Rebecca E Chandler, Kathryn M Edwards, Miriam C J M Sturkenboom

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

During the roll out of vaccines during a pandemic, questions regarding vaccine safety often arise. This was surely true during the SARS-CoV-2 pandemic. Different tools and capabilities exist during the pre-authorization phase and post introduction each with its strengths and limitations. Here we review the various tools and their strengths and limitations and discuss what functioned well in high income settings and the limitations that unequal vaccine safety pharmacovigilance capacity imposed upon middle and low income countries.

Original languageEnglish
Pages (from-to)3790-3795
Number of pages6
JournalVaccine
Volume41
Issue number25
DOIs
Publication statusPublished - 7 Jun 2023

Keywords

  • COVID-19/prevention & control
  • Humans
  • Pandemics/prevention & control
  • Pharmacovigilance
  • SARS-CoV-2
  • Vaccines/adverse effects

Fingerprint

Dive into the research topics of 'Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future'. Together they form a unique fingerprint.

Cite this